Nymox Pharmaceutical
NYMX
#10189
Rank
โ‚ฌ15.67 M
Marketcap
Country
0,17ย โ‚ฌ
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Nymox Pharmaceutical (NYMX) - Net assets

Net assets on the balance sheet as of June 2023 : -โ‚ฌ2.48 Million

According to Nymox Pharmaceutical's latest financial reports the company has -โ‚ฌ2.48 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Nymox Pharmaceutical - Net assets on balance sheet (from 2001 to 2023)

Net assets by year

Year Net assets Change
2022-12-31$-โ‚ฌ0.45 Million0.57%
2021-12-31$-โ‚ฌ0.45 Million-125.62%
2020-12-31$โ‚ฌ1.74 M-43.34%
2019-12-31$โ‚ฌ3.07 M-49.71%
2018-12-31$โ‚ฌ6.12 M-687.04%
2017-12-31$-โ‚ฌ1.05 Million70.98%
2016-12-31$-โ‚ฌ0.61 Million-75.78%
2015-12-31$-โ‚ฌ2.52 Million-26.76%
2014-12-31$-โ‚ฌ3.44 Million-21.64%
2013-12-31$-โ‚ฌ4.39 Million-22.05%
2012-12-31$-โ‚ฌ5.63 Million40.62%
2011-12-31$-โ‚ฌ4.01 Million86.49%
2010-12-31$-โ‚ฌ2.15 Million111.74%
2009-12-31$-โ‚ฌ1.02 Million-150.41%
2008-12-31$โ‚ฌ2.01 M-1.01%
2007-12-31$โ‚ฌ2.03 M46.73%
2006-12-31$โ‚ฌ1.38 M35.28%
2005-12-31$โ‚ฌ1.02 M-31.03%
2004-12-31$โ‚ฌ1.48 M-22.13%
2003-12-31$โ‚ฌ1.9 M-31.02%
2002-12-31$โ‚ฌ2.76 M-29.2%
2001-12-31$โ‚ฌ3.9 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Abbott Laboratories
ABT
โ‚ฌ44.03 B-1,781,956.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ79.96 B-3,235,970.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚ฌ6.33 B-256,478.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ20.48 B-829,116.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ68.09 B-2,755,643.97%๐Ÿ‡บ๐Ÿ‡ธ USA